ABCDx SA

Diagnosis point of care for stroke and TBI

ABCDx provides powerful new tools for transforming the triage, diagnosis and treatment decision process at the point of care for patients presenting with potential brain injury from stroke and trauma to complications. ABCDx is pioneering the ability to decode the chemical messages of the brain so that brain injury can be detected earlier often before hospitalization and from a single blood drop.
Currently, ABCDx is developing biomarker panels for three products: TBICheck™ for traumatic brain injuries, STROKECheck™ for differentiating between ischemic and haemorrhagic stroke and LVOCheck™ for triage of stroke patients with large vessel occlusions.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

21.02.2024

ABCDx’s clinical study on diagnostic stroke device in full swing (startupticker.ch)

17.12.2021

ABCDx, Neurosoft and HekeTiss supported by FONGIT Innovation Fund (startupticker.ch)

01.12.2020

ABCDx to submit StrokeCheck for clearance in the US & EU (startupticker.ch)

02.08.2018

ABCDx raises funds for clinical trials of its traumatic brain Injury solution (startupticker.ch)

No milestones

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (10'000) 2018

Website